(Total Views: 226)
Posted On: 11/22/2021 1:50:51 PM
Post# of 44

$AFMD News Article - Affimed Announces 100% Objective Response Rate at Highest Dose in Phase 1-2 Study of Cord Blood-derived Natural Killer Cells Pre-complexed with Innate Cell Engager AFM13 for CD30-positive Lymphomas https://marketwirenews.com/news-releases/affi...61351.html


My Twitter: WhyteStocks